Cameron D. Willis
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Cameron D. Willis has a total of 19 co-authors. Here are the top co-authors by number of shared publications:
- Janet Esther Hiller
Australian Catholic University, Melbourne, Victoria, Australia
4 shared publications - Adam G. Elshaug
Centre for Health Policy University of Melbourne Melbourne Australia
3 shared publications - Peter Alistair Cameron
School of Public Health and Preventive Medicine, Monash University, Melbourne, Victoria, Australia
2 shared publications Allan Best
Centre for Clinical Epidemiology and Evaluation, Vancouver Coastal Health Research Institute, Vancouver, British Columbia, Canada
1 shared publicationAmber M. Watt
School of Population Health and Clinical Practice, The University of Adelaide, South Australia
1 shared publication- Amber M. Watt
The University of Adelaide
1 shared publication
Latest Publications
- 17 June 2013
- Published by AMPCo in Medical Journal of Australia
- Vol. 198 (11) , 586-588
Vitamin B12 and folate tests: the ongoing need to determine appropriate use and public funding
Vitamin B12 and folate tests: the ongoing need to determine appropriate use and public funding
- 17 June 2013
- Published by AMPCo in Medical Journal of Australia
- Vol. 198 (11) , 586-588
Vitamin B12 and folate tests: the ongoing need to determine appropriate use and public funding
Vitamin B12 and folate tests: the ongoing need to determine appropriate use and public funding
- 4 January 2013
- Published by Springer Nature in Breast Cancer Research and Treatment
- Vol. 137 (3) , 665-676
A systematic review of elastography, electrical impedance scanning, and digital infrared thermography for breast cancer screening and diagnosis
The objective of this study aimed to systematically identify and evaluate all the available evidence of safety, effectiveness and diagnostic accuracy for three emerging classes of technology promoted for breast cancer screening and diagnosis: Digital infrared thermal imaging (DITI), electrical impedance scanning (EIS) and elastography. A systematic search of seven biomedical databases (EMBASE, PubMed, Web of Science, CRD, CINAHL, Cochrane Library, Current Contents Connect) was conducted through March 2011, along with a manual search of reference lists from relevant studies. The principal outcome measures were safety, effectiveness, and diagnostic accuracy. Data were extracted using a standardised form, and validated for accuracy by the secondary authors. Study quality was appraised using the quality assessment of diagnostic accuracy studies tool, while heterogeneity was assessed using forest plots, Cooks’ distance and standardised residual scatter plots, and I 2 statistics. From 6,808 search results, 267 full-text articles were assessed, of which 60 satisfied the inclusion criteria. No effectiveness studies were identified. Only one EIS screening accuracy study was identified, while all other studies involved symptomatic populations. Significant heterogeneity was present among all device classes, limiting the potential for meta-analyses. Sensitivity and specificity varied greatly for DITI (Sens 0.25–0.97, Spec 0.12–0.85), EIS (Sens 0.26–0.98, Spec 0.08–0.81) and ultrasound elastography (Sens 0.35–1.00, Spec 0.21–0.99). It is concluded that there is currently insufficient evidence to recommend the use of these technologies for breast cancer screening. Moreover, the high level of heterogeneity among studies of symptomatic women limits inferences that may be drawn regarding their use as diagnostic tools. Future research employing standardised imaging, research and reporting methods is required.
- 4 January 2013
- Published by Springer Nature in Breast Cancer Research and Treatment
- Vol. 137 (3) , 665-676
A systematic review of elastography, electrical impedance scanning, and digital infrared thermography for breast cancer screening and diagnosis
The objective of this study aimed to systematically identify and evaluate all the available evidence of safety, effectiveness and diagnostic accuracy for three emerging classes of technology promoted for breast cancer screening and diagnosis: Digital infrared thermal imaging (DITI), electrical impedance scanning (EIS) and elastography. A systematic search of seven biomedical databases (EMBASE, PubMed, Web of Science, CRD, CINAHL, Cochrane Library, Current Contents Connect) was conducted through March 2011, along with a manual search of reference lists from relevant studies. The principal outcome measures were safety, effectiveness, and diagnostic accuracy. Data were extracted using a standardised form, and validated for accuracy by the secondary authors. Study quality was appraised using the quality assessment of diagnostic accuracy studies tool, while heterogeneity was assessed using forest plots, Cooks’ distance and standardised residual scatter plots, and I 2 statistics. From 6,808 search results, 267 full-text articles were assessed, of which 60 satisfied the inclusion criteria. No effectiveness studies were identified. Only one EIS screening accuracy study was identified, while all other studies involved symptomatic populations. Significant heterogeneity was present among all device classes, limiting the potential for meta-analyses. Sensitivity and specificity varied greatly for DITI (Sens 0.25–0.97, Spec 0.12–0.85), EIS (Sens 0.26–0.98, Spec 0.08–0.81) and ultrasound elastography (Sens 0.35–1.00, Spec 0.21–0.99). It is concluded that there is currently insufficient evidence to recommend the use of these technologies for breast cancer screening. Moreover, the high level of heterogeneity among studies of symptomatic women limits inferences that may be drawn regarding their use as diagnostic tools. Future research employing standardised imaging, research and reporting methods is required.
- 30 November 2011
- Published by BMJ in BMJ Quality & Safety
- Vol. 21 (3) , 250-262
System tools for system change
Background: Health system transformations are influenced by dynamic relationships within and between individuals and institutions, as well as political, educational and legislative factors. This article aims to promote awareness of five tools that recognise this complexity and that are proposed to have value for decision makers: concept mapping, social network analysis, system dynamics modelling, programme budgeting and marginal analysis, and the tools for knowledge management and translation.Methods: The authors briefly describe the methodological approach of each tool, provide a commentary on the conditions in which these tools have been employed, and discuss their impact on the processes and outcomes of system transformation. An international advisory panel was convened based on a combination of experience, expertise and perspective. The panel assisted in synthesising the evidence relating to each tool and, in partnership with the authors, refined the interpretation of the role and value of each tool for system transformation.Findings: The tools discussed may impact the structural and procedural outcomes of transformation as well as the values, behaviours and attitudes of people undergoing change. The techniques described provide those undertaking transformation with methods to negotiate clinical, academic, political, organisational and cultural perspectives, and recognise the pivotal role of context in transformation.Conclusions: This review offers a novel synthesis of how these tools may add value to decision making for health policy. The tools discussed, while not a panacea to the challenges of large system change, provide methods that acknowledge the complexity of the transformative challenge and present innovative paths to co-produced solutions.
- 30 November 2011
- Published by BMJ in BMJ Quality & Safety
- Vol. 21 (3) , 250-262
System tools for system change
Background: Health system transformations are influenced by dynamic relationships within and between individuals and institutions, as well as political, educational and legislative factors. This article aims to promote awareness of five tools that recognise this complexity and that are proposed to have value for decision makers: concept mapping, social network analysis, system dynamics modelling, programme budgeting and marginal analysis, and the tools for knowledge management and translation.Methods: The authors briefly describe the methodological approach of each tool, provide a commentary on the conditions in which these tools have been employed, and discuss their impact on the processes and outcomes of system transformation. An international advisory panel was convened based on a combination of experience, expertise and perspective. The panel assisted in synthesising the evidence relating to each tool and, in partnership with the authors, refined the interpretation of the role and value of each tool for system transformation.Findings: The tools discussed may impact the structural and procedural outcomes of transformation as well as the values, behaviours and attitudes of people undergoing change. The techniques described provide those undertaking transformation with methods to negotiate clinical, academic, political, organisational and cultural perspectives, and recognise the pivotal role of context in transformation.Conclusions: This review offers a novel synthesis of how these tools may add value to decision making for health policy. The tools discussed, while not a panacea to the challenges of large system change, provide methods that acknowledge the complexity of the transformative challenge and present innovative paths to co-produced solutions.
- 1 October 2011
- Published by Elsevier in Health Policy
- Vol. 102 (2-3) , 200-213
Assisted reproductive technologies: A systematic review of safety and effectiveness to inform disinvestment policy
- 1 October 2011
- Published by Elsevier in Health Policy
- Vol. 102 (2-3) , 200-213
Assisted reproductive technologies: A systematic review of safety and effectiveness to inform disinvestment policy
- Open Access
- 25 March 2011
- Published by Oxford University Press (OUP) in International Journal for Quality in Health Care
- Vol. 23 (3) , 317-323
Identifying and improving unreliable items in registries through data auditing
Assessing the reliability of clinical registries is important for ensuring the availability of credible data. Therefore, this study aimed to investigate the reliability of data collected by the Australian and New Zealand Haemostasis Registry (the registry). Data from 5% of randomly selected registry cases were re-abstracted by an independent data auditor who was blinded to the results of the original data abstraction. Categorical data were investigated for agreement between original and re-abstracted data. The mean difference and standard deviations (SD) of differences were calculated for continuous variables. We estimated a ‘prediction interval’ as the mean difference ± twice the SD of differences. We computed a coefficient of variation as the SD of differences. The registry records all cases of off-licence use of recombinant activated factor VII (rFVIIa) at participating institutions (on-licence use of rFVIIa is not recorded). Data on 76 registry cases (6% of registry) were re-abstracted. Various parameters demonstrated high levels of inter-rater reliability, including age, gender and intensive care unit admission (88, 99 and 99% agreement, respectively). Other variables were highly unreliable, including crystalloid infusion volumes (coefficient of variation 123.01%), red blood cell units (92.05%) and time from bleeding onset to administration of rFVIIa (153.06%). Registry audits are useful for identifying variables with poor reliability. Repeated audits will not improve data reliability; however, they can assist in identifying and evaluating the impact of modified data collection processes on improving data reliability.
- 25 March 2011
- Published by Oxford University Press (OUP) in International Journal for Quality in Health Care
- Vol. 23 (3) , 317-323
Open AccessIdentifying and improving unreliable items in registries through data auditing
Assessing the reliability of clinical registries is important for ensuring the availability of credible data. Therefore, this study aimed to investigate the reliability of data collected by the Australian and New Zealand Haemostasis Registry (the registry). Data from 5% of randomly selected registry cases were re-abstracted by an independent data auditor who was blinded to the results of the original data abstraction. Categorical data were investigated for agreement between original and re-abstracted data. The mean difference and standard deviations (SD) of differences were calculated for continuous variables. We estimated a ‘prediction interval’ as the mean difference ± twice the SD of differences. We computed a coefficient of variation as the SD of differences. The registry records all cases of off-licence use of recombinant activated factor VII (rFVIIa) at participating institutions (on-licence use of rFVIIa is not recorded). Data on 76 registry cases (6% of registry) were re-abstracted. Various parameters demonstrated high levels of inter-rater reliability, including age, gender and intensive care unit admission (88, 99 and 99% agreement, respectively). Other variables were highly unreliable, including crystalloid infusion volumes (coefficient of variation 123.01%), red blood cell units (92.05%) and time from bleeding onset to administration of rFVIIa (153.06%). Registry audits are useful for identifying variables with poor reliability. Repeated audits will not improve data reliability; however, they can assist in identifying and evaluating the impact of modified data collection processes on improving data reliability.
- 16 August 2010
- Published by Wiley in Anz Journal of Surgery
- Vol. 80 (11) , 802-806
Predicting trauma patient mortality: ICD [or ICD‐10‐AM] versus AIS based approaches
Background: The International Classification of Diseases Injury Severity Score (ICISS) has been proposed as an International Classification of Diseases (ICD)‐10‐based alternative to mortality prediction tools that use Abbreviated Injury Scale (AIS) data, including the Trauma and Injury Severity Score (TRISS). To date, studies have not examined the performance of ICISS using Australian trauma registry data. This study aimed to compare the performance of ICISS with other mortality prediction tools in an Australian trauma registry.Methods: This was a retrospective review of prospectively collected data from the Victorian State Trauma Registry. A training dataset was created for model development and a validation dataset for evaluation. The multiplicative ICISS model was compared with a worst injury ICISS approach, Victorian TRISS (V‐TRISS, using local coefficients), maximum AIS severity and a multivariable model including ICD‐10‐AM codes as predictors. Models were investigated for discrimination (C‐statistic) and calibration (Hosmer–Lemeshow statistic).Results: The multivariable approach had the highest level of discrimination (C‐statistic 0.90) and calibration (H–L 7.65, P= 0.468). Worst injury ICISS, V‐TRISS and maximum AIS had similar performance. The multiplicative ICISS produced the lowest level of discrimination (C‐statistic 0.80) and poorest calibration (H–L 50.23, P < 0.001).Conclusions: The performance of ICISS may be affected by the data used to develop estimates, the ICD version employed, the methods for deriving estimates and the inclusion of covariates. In this analysis, a multivariable approach using ICD‐10‐AM codes was the best‐performing method. A multivariable ICISS approach may therefore be a useful alternative to AIS‐based methods and may have comparable predictive performance to locally derived TRISS models.
- 16 August 2010
- Published by Wiley in Anz Journal of Surgery
- Vol. 80 (11) , 802-806
Predicting trauma patient mortality: ICD [or ICD‐10‐AM] versus AIS based approaches
Background: The International Classification of Diseases Injury Severity Score (ICISS) has been proposed as an International Classification of Diseases (ICD)‐10‐based alternative to mortality prediction tools that use Abbreviated Injury Scale (AIS) data, including the Trauma and Injury Severity Score (TRISS). To date, studies have not examined the performance of ICISS using Australian trauma registry data. This study aimed to compare the performance of ICISS with other mortality prediction tools in an Australian trauma registry.Methods: This was a retrospective review of prospectively collected data from the Victorian State Trauma Registry. A training dataset was created for model development and a validation dataset for evaluation. The multiplicative ICISS model was compared with a worst injury ICISS approach, Victorian TRISS (V‐TRISS, using local coefficients), maximum AIS severity and a multivariable model including ICD‐10‐AM codes as predictors. Models were investigated for discrimination (C‐statistic) and calibration (Hosmer–Lemeshow statistic).Results: The multivariable approach had the highest level of discrimination (C‐statistic 0.90) and calibration (H–L 7.65, P= 0.468). Worst injury ICISS, V‐TRISS and maximum AIS had similar performance. The multiplicative ICISS produced the lowest level of discrimination (C‐statistic 0.80) and poorest calibration (H–L 50.23, P < 0.001).Conclusions: The performance of ICISS may be affected by the data used to develop estimates, the ICD version employed, the methods for deriving estimates and the inclusion of covariates. In this analysis, a multivariable approach using ICD‐10‐AM codes was the best‐performing method. A multivariable ICISS approach may therefore be a useful alternative to AIS‐based methods and may have comparable predictive performance to locally derived TRISS models.